Living Evidence Synthesis and Reviews

Chimeric antigen receptor T cell therapy for hematological malignancies

Mechanical assist devices in cardiovascular diseases

Glucagon-like peptide analogues and agonists in type II diabetes mellitus

Negative-pressure wound therapy for
Chronic ulcers

Remdesivir for

School closures for

Bevacizumab, Olaparib, Rucaparib and Niraparib for ovarian cancer

Three-dimensional mammography for
breast cancer

Fecal microbiota transplant for ulcerative colitis